NCT04185883 2025-10-22
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
Amgen
Phase 1 Active not recruiting
Clinical Trials
5 trialsNCT04497584 2025-10-01
Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC
University of Texas Southwestern Medical Center
Phase 2 Active not recruiting
NCT03785249 2025-09-30
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
Mirati Therapeutics Inc.
Phase 1/2 Active not recruiting
NCT05215548 2025-02-19
Primary Tumor Resection With EGFR TKI for Stage IV NSCLC
National Taiwan University Hospital
Phase 2 Active not recruiting
NCT01553942 2024-11-20
Afatinib With CT and RT for EGFR-Mutant NSCLC
Massachusetts General Hospital
Phase 2 Active not recruiting